J j profits from motrin

Apr 16, 2013 Johnson amp Johnson39s first-quarter profit fell by just over 10 percent as That39s kept Tylenol, Motrin and many other JampJ staples out of stores children39s medicines. Tylenol, Motrin, Zyrtec and Benadryl products were affected. Annual revenue: US63.75 billion Increase 4.3 (FY 2008) Annual net

Nov 23, 2010 New JampJ recalls hit Benadryl, Motrin, Rolaids The Benadryl and Motrin recalls were initiated after a JampJ review revealed Profitable Trading

Feb 21, 2012 Alex Gorsky, JampJ39s head of pharmaceuticals in Europe, the Middle East and Africa , to conduct a clandestine recall of more than 88,000 Motrin tablets. JampJ chose profit margins over compliance with the law by acquiring a Apr 15, 2014 The consumer products business has been hit by dozens of recalls since 2009 for products including pain relievers Tylenol and Motrin. JampJ is Nov 20, 2011 As JampJ39s profits last year swelled to a record 13 billion, the . for failing to tell the public that batches of Motrin, a pain reliever manufactured at

JampJ Q1 profit falls 10 pct despite higher sales

Johnson amp Johnson: Still A Great Income Stock, If A Bit Expensive (JNJ) Q4 2014 Johnson amp Johnson Earnings Release - 9:30AM EST - Add to calendar Amgen, AstraZeneca39s brodalumab beats JampJ39s Stelara in 2nd PhIII psoriasis . Recall of Tylenol, Motrin, and other products (27.5 decrease in revenue from

Aug 19, 2010 The company has been less than forthcoming about the Motrin . At the end of 2006, JampJ, on the hunt for growth amid slowing sales and profits, Apr 16, 2013 JampJ pulled millions of packages and bottles of consumer meds in 2010, including signature product lines like Tylenol and Motrin, because of